Status:
COMPLETED
Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours
Lead Sponsor:
Walter and Eliza Hall Institute of Medical Research
Collaborating Sponsors:
Royal Marsden NHS Foundation Trust
Melbourne Health
Conditions:
Testicular Neoplasms
Eligibility:
MALE
Brief Summary
Recent data (Srikanthan and Tran et al. JCO 2014, in press) have demonstrated that the presence of large retroperitoneal lymph node metastases on baseline staging scans (measuring \>5cm in axial dimen...
Detailed Description
Recent data (Srikanthan and Tran et al. JCO 2014, in press) have demonstrated that the presence of large retroperitoneal lymph node (RPLN) metastases on baseline staging scans (measuring \>5cm in axia...
Eligibility Criteria
Inclusion
- Men with disseminated GCT (AJCC Stage IS, 2, or 3)
- Received first line chemotherapy with curative intent for disseminated GCT
- Clinical data available from chemotherapy initiation to at least 90 days following completion of chemotherapy (patients who died prior to 90 days will be included in this study)
- Initiated chemotherapy between 1-January-2000 and 31-December-2014\* \*Data collection from consecutive patients initiating chemotherapy during a defined period within the specified timeframe is acceptable (e.g. patient data from 5-year period starting 1-January-2008 and ending 31-December-2012 is acceptable)
Exclusion
- Prior chemotherapy for GCT (including use of adjuvant chemotherapy or curative chemotherapy for prior diagnosis of disseminated GCT).
- History of secondary malignancy (excluding non-melanoma superficial skin cancers)
Key Trial Info
Start Date :
December 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 16 2020
Estimated Enrollment :
1135 Patients enrolled
Trial Details
Trial ID
NCT04122430
Start Date
December 1 2015
End Date
October 16 2020
Last Update
October 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Walter and Eliza Hall Institute of Medical Research
Parkville, Victoria, Australia, 3052